EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.11.7 | medicine | the development of GluAP inhibitors as potential antihypertensive agents offers new perspectives of therapy | Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.11.2 | bestatin | - |
Rattus norvegicus | |
3.4.11.6 | bestatin | - |
Rattus norvegicus | |
3.4.11.7 | (R)-3-amino-4-mercaptobutane-1-sulfonic acid | i.e. EC33 | Rattus norvegicus | |
3.4.11.7 | 4,4'-dithio [bis[(3S)-3-aminobutyl sulfonic acid]] | i.e. RB150 | Rattus norvegicus | |
3.4.11.21 | additional information | not inhibited by amastatin, bestatin, or EDTA | Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.11.2 | microsome | - |
Rattus norvegicus | - |
- |
3.4.11.21 | microsome | - |
Rattus norvegicus | - |
- |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.11.7 | angiotensin II + H2O | Rattus norvegicus | angiotensin II: Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | aspartic acid + angiotensin III | angiotensin III: Arg-Val-Tyr-Ile-His-Pro-Phe | ? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.11.2 | Rattus norvegicus | - |
- |
- |
3.4.11.6 | Rattus norvegicus | - |
- |
- |
3.4.11.7 | Rattus norvegicus | - |
Wistar-Kyoto and Sprague-Dawley rat | - |
3.4.11.21 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.11.2 | brain | - |
Rattus norvegicus | - |
3.4.11.7 | brain | - |
Rattus norvegicus | - |
3.4.11.21 | brain | - |
Rattus norvegicus | - |
3.4.11.21 | kidney | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.11.2 | angiotensin III + H2O | - |
Rattus norvegicus | angiotensin IV + L-Arg | - |
? | |
3.4.11.6 | angiotensin III + H2O | - |
Rattus norvegicus | angiotensin IV + ? | - |
? | |
3.4.11.6 | L-Arg-2-naphthylamide + H2O | - |
Rattus norvegicus | L-Arg + 2-naphthylamine | - |
? | |
3.4.11.7 | angiotensin II + H2O | angiotensin II: Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | Rattus norvegicus | aspartic acid + angiotensin III | angiotensin III: Arg-Val-Tyr-Ile-His-Pro-Phe | ? | |
3.4.11.21 | angiotensin I + H2O | - |
Rattus norvegicus | Asp + des-Asp-angiotensin I | - |
? | |
3.4.11.21 | Asp-2-naphthylamide + H2O | most susceptible substrate | Rattus norvegicus | Asp + 2-naphthylamine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.11.2 | AlaAP | - |
Rattus norvegicus |
3.4.11.2 | aminopeptidase M | - |
Rattus norvegicus |
3.4.11.2 | LeuAP M | - |
Rattus norvegicus |
3.4.11.2 | microsomal leucine aminopeptidase | - |
Rattus norvegicus |
3.4.11.6 | ArgAP | - |
Rattus norvegicus |
3.4.11.6 | arginine aminopeptidase | - |
Rattus norvegicus |
3.4.11.7 | aminopeptidase A | - |
Rattus norvegicus |
3.4.11.7 | GluAP | - |
Rattus norvegicus |
3.4.11.7 | glutamyl aminopeptidase | - |
Rattus norvegicus |
3.4.11.21 | AspAP | considered initially an alternative name for glutamyl aminopeptidase | Rattus norvegicus |